Immix Biopharma, Inc. Common Stock (NASDAQ: IMMX) last traded at $9.25, down 2.22% on the session. The quote above updates while this page is open; the figures below are drawn from Immix Biopharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Immix Biopharma, Inc. Common Stock trades on NASDAQ under the ticker IMMX. Its market capitalisation is $661.74 million.
Valuation measures for Immix Biopharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $661.74M |
|---|---|
| Enterprise value | $446.44M |
| Price / book | 2.89 |
| Beta | 1.59 |
Trailing-twelve-month figures tagged in Immix Biopharma, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$39.88M |
| Return on equity | -17.42% |
|---|
| Cash | $225.49M |
|---|
Range and volume for IMMX over the past 52 weeks.
| 52-week high | $15.10 |
|---|---|
| 52-week low | $2.31 |
| Volume | 936.2K |
| Average volume | 1.63M |
| Previous close | $9.46 |
Invest a chosen dollar amount in Immix Biopharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IMMX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.